HER2 Support Group Forums - Enzon Opens A Phase 2 Study Of PEG-SN38 For Metastatic Breast Cancer

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)

- Breast Cancer Newsfeed (https://her2support.org/vbulletin/forumdisplay.php?f=52)

- - Enzon Opens A Phase 2 Study Of PEG-SN38 For Metastatic Breast Cancer (https://her2support.org/vbulletin/showthread.php?t=43235)

News	01-07-2010 10:10 AM

Enzon Opens A Phase 2 Study Of PEG-SN38 For Metastatic Breast Cancer

Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that the first patient has been treated in the Phase 2 studies of PEG-SN38 for metastatic breast cancer. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection)...

More...

All times are GMT -7. The time now is 11:16 AM.